Standout Papers

A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance an... 2021 2026 2022 2024220
  1. A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus (2021)
    William A. Fischer, Joseph J. Eron et al. Science Translational Medicine

Immediate Impact

11 from Science/Nature 73 standout
Sub-graph 1 of 23

Citing Papers

Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model
2024 StandoutScience
Three-year outcomes of post-acute sequelae of COVID-19
2024 Standout
4 intermediate papers

Works of Amy James Loftis being referenced

A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus
2021 Standout
Ebola Virus Ribonucleic Acid Detection in Semen More Than Two Years After Resolution of Acute Ebola Virus Infection
2017

Author Peers

Author Last Decade Papers Cites
Amy James Loftis 269 80 6 40 8 307
Paola Magro 164 36 7 27 13 265
Carolin M. Lieber 214 127 2 29 14 311
Yu Cong 252 163 17 18 359
Nina Breinholt Stærke 127 111 27 17 266
Ameema Asad 130 61 1 39 11 274
Srinivas Rao 294 88 10 15 6 368
Emily Mantlo 279 49 1 76 8 357
Derek L.L. Hung 172 47 3 47 11 310
Maaweya E. Hamed 219 114 1 46 13 327
Ikbel Hadj Hassine 203 39 4 24 7 292

All Works

Loading papers...

Rankless by CCL
2026